FDA Import Refusal 1FX-4670062-2/10002/1 — Hetro Health Care Ltd
The FDA refused shipment 1FX-4670062-2/10002/1 from Hetro Health Care Ltd (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — OSELTAMIVIR PHOSPHATE (ANTI-VIRAL). Cited charge: 75
Refusal Details
- Date
- Oct 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62VCL45 OSELTAMIVIR PHOSPHATE (ANTI-VIRAL)
- Charges
- 75